Arrowhead Pharmaceuticals, Inc.Arrowhead Pharmaceuticals, Inc.Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

45.540.000.00%
The 13 analysts offering 1 year price forecasts for ARWR have a max estimate of — and a min estimate of —.

Analyst rating

Based on 16 analysts giving stock ratings to ARWR in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ARWR EPS for the last quarter is −1.38 USD despite the estimation of −0.53 USD. In the next quarter EPS is expected to reach −0.97 USD. Track more of Arrowhead Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Arrowhead Pharmaceuticals, Inc. revenue is expected to reach ‪55.07 M‬ USD. Check out Arrowhead Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, ARWR price target is 45.54 USD with a max estimate of 71.00 USD and a min estimate of 20.00 USD. Check if this forecast comes true in a year, meanwhile watch Arrowhead Pharmaceuticals, Inc. stock price chart and keep track of the current situation with ARWR news and stock market news.
We've gathered opinions of 16 analysts rating ARWR stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.